| P50 | author | Edward K Geissler | Q114400579 |
| P2093 | author name string | Hans J Schlitt | |
| | Stefan A Farkas | |
| | Matthias Hornung | |
| | Christine Sattler | |
| P2860 | cites work | From immune activation to gut tissue injury: the pieces of the puzzle are coming together | Q73118394 |
| | CD4+ T lymphocytes injected into severe combined immunodeficient (SCID) mice lead to an inflammatory and lethal bowel disease | Q73215671 |
| | Requirement for Valpha14 NKT cells in IL-12-mediated rejection of tumors | Q73889862 |
| | Activation of natural killer T cells by alpha-galactosylceramide in the presence of CD1d provides protection against colitis in mice | Q73977788 |
| | Cd1d-restricted cellular lysis by peripheral blood lymphocytes: relevance to the inflammatory bowel diseases | Q74008220 |
| | Increased intracellular Th1 cytokines in scid mice with inflammatory bowel disease | Q74251744 |
| | Activation of natural killer T cells by alpha-galactosylceramide treatment prevents the onset and recurrence of autoimmune Type 1 diabetes | Q74455329 |
| | Long-term survival of corneal allografts is dependent on intact CD1d-reactive NKT cells | Q77584492 |
| | Quantification of murine cytokine mRNAs using real time quantitative reverse transcriptase PCR | Q77753107 |
| | CD1d-restricted immunoglobulin G formation to GPI-anchored antigens mediated by NKT cells | Q77764857 |
| | A novel recognition motif of human NKT antigen receptor for a glycolipid ligand | Q77849962 |
| | Adoptive transfer of small numbers of DX5+ cells alleviates graft-versus-host disease in a murine model of semiallogeneic bone marrow transplantation: a potential role for NKT lymphocytes | Q81042784 |
| | Preferential migration of CD62L cells into the appendix in mice with experimental chronic colitis | Q81767311 |
| | Inflammatory Bowel Disease | Q22248115 |
| | Immunolocalization of CD1d in human intestinal epithelial cells and identification of a beta2-microglobulin-associated form | Q28142658 |
| | The B7 family revisited | Q28240070 |
| | CD1: antigen presentation and T cell function | Q28251508 |
| | CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides | Q28254991 |
| | Natural ligand of mouse CD1d1: cellular glycosylphosphatidylinositol. | Q32105308 |
| | CD1-mediated immune responses to glycolipids | Q33664794 |
| | CD1d ligation on human monocytes directly signals rapid NF-kappaB activation and production of bioactive IL-12. | Q33920135 |
| | Animal models of intestinal inflammation: new insights into the molecular pathogenesis and immunotherapy of inflammatory bowel disease | Q34011662 |
| | CD1d-restricted mouse V alpha 14 and human V alpha 24 T cells: lymphocytes of innate immunity | Q34123048 |
| | Phenotypically distinct subsets of CD4+ T cells induce or protect from chronic intestinal inflammation in C. B-17 scid mice | Q34321778 |
| | Co-inhibitory molecules of the B7-CD28 family in the control of T-cell immunity | Q35762422 |
| | CD1 assembly and the formation of CD1-antigen complexes | Q36011015 |
| | Recognition of lipid antigens by T cells | Q36146922 |
| | Innate immunity: NKT cells in the spotlight | Q36151955 |
| | Regulatory interactions between CD45RBhigh and CD45RBlow CD4+ T cells are important for the balance between protective and pathogenic cell-mediated immunity. | Q36362779 |
| | An invariant T cell receptor alpha chain is used by a unique subset of major histocompatibility complex class I-specific CD4+ and CD4-8- T cells in mice and humans. | Q36363643 |
| | Natural killer T cell activation protects mice against experimental autoimmune encephalomyelitis. | Q36369797 |
| | Activation of natural killer T cells potentiates or prevents experimental autoimmune encephalomyelitis | Q36369830 |
| | Requirements for CD1d recognition by human invariant Valpha24+ CD4-CD8- T cells | Q36380304 |
| | Ligation of intestinal epithelial CD1d induces bioactive IL-10: critical role of the cytoplasmic tail in autocrine signaling | Q36703897 |
| | Structural requirements for antigen presentation by mouse CD1 | Q37421040 |
| | Lysosomal glycosphingolipid recognition by NKT cells | Q40493118 |
| | A new model of chronic colitis in SCID mice induced by adoptive transfer of CD62L+ CD4+ T cells: insights into the regulatory role of interleukin-6 on apoptosis | Q40606609 |
| | Treatment of T cell-dependent experimental colitis in SCID mice by local administration of an adenovirus expressing IL-18 antisense mRNA. | Q40761660 |
| | Mouse CD1-specific NK1 T cells: development, specificity, and function | Q41464349 |
| | Oxazolone colitis, a Th2 colitis model resembling ulcerative colitis, is mediated by IL-13-producing NK-T cells | Q44217456 |
| | Blockade of B7-H1 Suppresses the Development of Chronic Intestinal Inflammation | Q47581760 |
| | NKT cells: what's in a name? | Q47895830 |
| | Inflammatory bowel disease: etiology and pathogenesis | Q47899867 |
| | Contrasting activity of cytosin–guanosin dinucleotide oligonucleotides in mice with experimental colitis | Q54056924 |
| | DX5/CD49b-Positive T Cells Are Not Synonymous with CD1d-Dependent NKT Cells | Q57082202 |
| | The natural killer T-cell ligand α-galactosylceramide prevents autoimmune diabetes in non-obese diabetic mice | Q63363340 |
| | Severe colitis in mice with aberrant thymic selection | Q71915303 |
| | Neutralization of tumour necrosis factor (TNF) but not of IL-1 reduces inflammation in chronic dextran sulphate sodium-induced colitis in mice | Q73068273 |
| P433 | issue | 5 | |
| P304 | page(s) | 1210-1221 | |
| P577 | publication date | 2006-05-01 | |
| P1433 | published in | European Journal of Immunology | Q5412727 |
| P1476 | title | DX5+ NKT cells induce the death of colitis-associated cells: involvement of programmed death ligand-1 | |
| P478 | volume | 36 | |